Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept and Gemcitabine in Advanced Pancreatic Cancer
NCT00201838Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Jul 2001
- Primary completion
- Oct 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in pancreatic adenocarcinoma (PDAC), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Jul 2001; status: completed.
02
Drugs
etanercept
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00201838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201838.